$treet Trader Lion's Den

[naturallyk2]

VIAP should be a great play!

VIA Pharmaceuticals, Inc., a biotechnology company, focuses on developing compounds for the treatment cardiovascular diseases. The company is building a pipeline of small-molecule drugs that target inflammation in the blood vessel wall, an underlying cause of atherosclerosis and its complications, including heart attack and stroke. Its pipeline includes small molecule anti-inflammatory drugs that intervene directly in vascular inflammation pathways. The company's principal product, VIA-2291, is in two concurrent Phase II clinical studies in patients with acute coronary syndrome and patients with carotid artery stenosis. VIA Pharmaceuticals was founded in 2004 and is headquartered in San Francisco, California.

It's been tradings in a very small range for the past month almost with expected release of clinical data from phase testing. This could very well possibly be a 10 bagger. Check it out!


http://www.viapharmaceuticals.com/